Correction to: Nature Reviews Nephrology https://doi.org/10.1038/s41581-024-00926-x, published online 15 January 2025.

In the version of the article initially published, the first point in Box 5 was inadvertently truncated and has now been corrected to read “We recommend treating children and adolescents (aged 1–17 years) with X-linked hypophosphataemia (XLH) and signs of rickets including leg deformities, elevated total ALP, and/or radiological evidence of rickets with burosumab as soon as the diagnosis is established (grade B, moderate recommendation)” in the HTML and PDF versions of the article.